Breaking News

Lonza Inks Development and Mfg. Pact for Bioqube’s Portfolio Co.s

Lonza to provide tailored services for molecules ranging from monoclonal antibodies, complex proteins, and small molecules to antibody-drug conjugates.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bioqube Ventures, a European venture capital firm, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, entered a strategic collaboration for the development and manufacturing of biologics and small molecules.   The agreement aims to support the needs of the venture capital company (VC) and its portfolio companies looking to simplify the development of their molecules. Under the agreement, Lonza will support Bioqube Ventures during the due ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters